Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 70% · prior close shown (market closed)
Assembling VTGN’s snapshot from earnings signals…
Updated
What happened recently for Vistagen Therapeutics, Inc. (VTGN) — events, not interpretation.
Research & analysis only — not investment advice.
Loading earnings intelligence…
US equity research on AlphaOS
Vistagen Therapeutics, Inc. Q4 2025: revenue +29.5% YoY
Vistagen Therapeutics, Inc. key market context on AlphaOS includes Market capitalization: $10.82M; Recent price: $0.24. Figures update as market data and SEC filings are ingested.
Use this VTGN research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Vistagen Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
